72 related articles for article (PubMed ID: 7665938)
1. Serum levels of tumour necrosis factor- alpha in schistosomiasis mansoni and their analogous changes in collagen diseases and schistosomal arthropathy.
Khalil HM; el-Missiry AG; Abdalla HM; Khalil NM; Sabry NM; Abdel-Atty HE; Tamara FA; el-Tayeb M; Zakaria NM
J Egypt Soc Parasitol; 1995 Aug; 25(2):427-36. PubMed ID: 7665938
[TBL] [Abstract][Full Text] [Related]
2. Study of interleukin-2 receptor in schistosomiasis mansoni and its analogous changes in collagen diseases and schistosomal arthropathy.
Khalil HM; el Missiry AG; Fahmy HM; Khalil NM; Nadia ; Sabry M; Abdel Atty HE; Tamara FA; Amer N; el Baz HG
J Egypt Soc Parasitol; 1995 Aug; 25(2):289-302. PubMed ID: 7665927
[TBL] [Abstract][Full Text] [Related]
3. Study of gamma-interferon in schistosomiasis mansoni, autoimmune diseases and schistosomal arthropathy.
Abdel-Aaty HE; Selim MM; Abdel-Rehim HA
J Egypt Soc Parasitol; 1999; 29(3):721-34. PubMed ID: 12561913
[TBL] [Abstract][Full Text] [Related]
4. Flowcytometric analysis of T-lymphocytes and serum tumour necrosis factor alpha (TNF-alpha) levels in schistosoma mansoni patients.
Shahat SA; El-Dhshan MA; Aissa SS; Dorra A; Metwally KM
J Egypt Soc Parasitol; 2007 Dec; 37(3):1065-74. PubMed ID: 18383806
[TBL] [Abstract][Full Text] [Related]
5. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
7. [The level of the tumor necrosis factor in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
Prokop'ev AA; Alekseeva TG; Zimina ZV; Ketlinskiĭ SA
Ter Arkh; 1993; 65(5):9-12. PubMed ID: 8036608
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
Rosenau BJ; Schur PH
J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453
[TBL] [Abstract][Full Text] [Related]
9. Raised serum APRIL levels in patients with systemic lupus erythematosus.
Koyama T; Tsukamoto H; Miyagi Y; Himeji D; Otsuka J; Miyagawa H; Harada M; Horiuchi T
Ann Rheum Dis; 2005 Jul; 64(7):1065-7. PubMed ID: 15576416
[TBL] [Abstract][Full Text] [Related]
10. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
Hegazy M; Darwish H; Darweesh H; El-Shehaby A; Emad Y
Clin Immunol; 2010 Apr; 135(1):118-24. PubMed ID: 20116334
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
13. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
Lub-de Hooge MN; de Vries EG; de Jong S; Bijl M
Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
[TBL] [Abstract][Full Text] [Related]
14. [The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
Ketlinskiĭ SA; Alekseeva TG; Perumov ND; Simbirtsev AS
Ter Arkh; 1993; 65(12):51-4. PubMed ID: 8146772
[TBL] [Abstract][Full Text] [Related]
15. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.
Damián-Abrego GN; Cabiedes J; Cabral AR
Lupus; 2008 Apr; 17(4):300-4. PubMed ID: 18413411
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
17. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
[TBL] [Abstract][Full Text] [Related]
18. Immune complexes as monitors of cure in Schistosoma mansoni infected mice.
Khalil HM; Bebars MA; Abdallah HM; Khalil NM; el Zayyat EA; Ismail MS
J Egypt Soc Parasitol; 1995 Aug; 25(2):355-65. PubMed ID: 7665932
[TBL] [Abstract][Full Text] [Related]
19. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
20. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
